-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P6lDvxGqZdPF/42G+w5tdeTRP/K2f2yc+Lz6qs6zwtNboblZchjYUxn+B1Fczmvr feVsgvkPPHIQ02Uz6hvNrA== 0001072613-08-000435.txt : 20080214 0001072613-08-000435.hdr.sgml : 20080214 20080214130613 ACCESSION NUMBER: 0001072613-08-000435 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080214 DATE AS OF CHANGE: 20080214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BEIJING MED PHARM CORP CENTRAL INDEX KEY: 0001281696 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81506 FILM NUMBER: 08612065 BUSINESS ADDRESS: STREET 1: 1180 MAIN ST CITY: COVENTRY STATE: CT ZIP: 06238 BUSINESS PHONE: 860-538-6630 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ASHFORD CAPITAL MANAGEMENT INC CENTRAL INDEX KEY: 0000897070 IRS NUMBER: 510243208 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1 WALKER'S MILL ROAD STREET 2: P.O. BOX 4172 CITY: WILMINGTON STATE: DE ZIP: 19807 BUSINESS PHONE: 3026551750 MAIL ADDRESS: STREET 1: 1 WALKER'S MILL ROAD STREET 2: P.O. BOX 4172 CITY: WILMINGTON STATE: DE ZIP: 19807 SC 13G/A 1 sc13ga-beijing_15733.txt BEIJING MED-PHARM CORPORATION SC 13G/A ================================================================================ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2)* BEIJING MED-PHARM CORPORATION - -------------------------------------------------------------------------------- (NAME OF ISSUER) COMMON STOCK, $0.001 PAR VALUE PER SHARE** - -------------------------------------------------------------------------------- (TITLE OF CLASS OF SECURITIES) 077255107 - -------------------------------------------------------------------------------- (CUSIP NUMBER) DECEMBER 31, 2007 - -------------------------------------------------------------------------------- (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) - -------------------------------------------------------------------------------- CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE IS FILED: [X] RULE 13d-1(b) [_] RULE 13d-1(c) [_] RULE 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). **As some of the securities beneficially owned by the Reporting Person reflects warrants of the Issuer convertible into shares of common stock of the Issuer, the figures in this statement are reflected on an "as-converted" basis. ================================================================================ - ------------------- ----------------- CUSIP NO. 077255107 13G PAGE 2 OF 5 PAGES - ------------------- ----------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON: I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY): Ashford Capital Management, Inc. - ----- -------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ----- -------------------------------------------------------------------------- 3 SEC USE ONLY - ----- -------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 2,213,910 shares* NUMBER OF ----- ------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 0 shares EACH ----- ------------------------------------------------ REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH 2,213,910 shares* ----- ------------------------------------------------ 8 SHARED DISPOSITIVE POWER 0 shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,213,910 shares* - ----- -------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] - ----- -------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 7.23%** - ----- -------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON IA - -------------------------------------------------------------------------------- *Includes warrants exercisable into 87,400 shares of common stock of the Issuer. **As some of the securities beneficially owned by the Reporting Person reflects warrants of the Issuer convertible into shares of common stock of the Issuer, the figures in this statement are reflected on an "as-converted" basis. - ------------------- ----------------- CUSIP NO. 077255107 13G PAGE 3 OF 5 PAGES - ------------------- ----------------- ITEM 1. (a) Name of Issuer: Beijing Med-Pharm Corporation (b) Address of Issuer's Principal Executive Offices: 600 W. Germantown Pike, Suite 400, Plymouth Meeting, Pennsylvania 19462 ITEM 2. (a) Name of Person Filing: Ashford Capital Management, Inc. (b) Address of Principal Business Office or, if none, Residence: P.O. Box 4172, Wilmington, DE 19807 (c) Citizenship: A Delaware Corporation (d) Title of Class of Securities: Common Stock, $0.001 Par Value Per Share (e) CUSIP Number: 077255107 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SS.SS.240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: (a) |_| Broker or dealer registered under section 15 of the Act (b) |_| Bank as defined in section 3(a)(6) of the Act (c) |_| Insurance company as defined in section 3(a)(19) of the Act (d) |_| Investment company registered under section 8 of the Investment Company Act of 1940 (e) |X| An investment adviser in accordance with ss.240.13d-1(b)(1(ii) (E) (f) |_| An employee benefit plan or endowment fund in accordance with ss.240.13d-1(b)(1)(ii)(F) (g) |_| A parent holding company or control person in accordance with ss.240.13d-1(b)(1)(ii)(G) (h) |_| A savings association as defined in section 3(b) of the Federal Deposit Insurance Act (i) |_| A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (j) |_| Group, in accordance with ss.240.13d-1(b)-1(ii)(J) ITEM 4. OWNERSHIP Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: 2,213,910 shares* (b) Percent of Class: 7.23%** The foregoing percentage is calculated based on 30,536,508 shares of Common Stock reported to be outstanding as of November 10, 2007 in the Issuer's Quarterly Report filed on Form 10-Q. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 2,213,910 shares* (ii) Shared power to vote or to direct the vote: 0 shares - ------------------- ----------------- CUSIP NO. 077255107 13G PAGE 4 OF 5 PAGES - ------------------- ----------------- (iii) Sole power to dispose or to direct the disposition of: 2,213,910 shares* (iv) Shared power to dispose or to direct the disposition of: 0 shares ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following |_|. N/A ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON The shares reported by the Reporting Person, a registered investment advisor, are held in separate individual client accounts, two separate limited partnerships and nine commingled funds. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY N/A ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP N/A ITEM 9. NOTICE OF DISSOLUTION OF GROUP N/A ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. *Includes warrants exercisable into 87,400 shares of common stock of the Issuer. **As some of the securities beneficially owned by the Reporting Person reflects warrants of the Issuer convertible into shares of common stock of the Issuer, the figures in this statement are reflected on an "as-converted" basis. - ------------------- ----------------- CUSIP NO. 077255107 13G PAGE 5 OF 5 PAGES - ------------------- ----------------- SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 14, 2008 ASHFORD CAPITAL MANAGEMENT, INC. By: /s/ Anthony M. Petrucci ------------------------------------ Anthony M. Petrucci Chief Financial Officer and Chief Compliance Officer -----END PRIVACY-ENHANCED MESSAGE-----